Ab­Cellera and Cana­da to in­vest $500M+ to boost an­ti­body man­u­fac­tur­ing and re­search

Ab­Cellera, a Van­cou­ver-based an­ti­body man­u­fac­tur­er, re­ceived an in­vest­ment from the gov­ern­ment of Cana­da and the province of British Co­lum­bia.

The in­vest­ment will to­tal CA$701 mil­lion ($515.9 mil­lion) over the next eight years, with the fund­ing go­ing to­ward build­ing new in­fra­struc­ture to de­vel­op an­ti­body-based med­i­cines. This in­cludes a site to de­vel­op and man­u­fac­ture an­ti­body med­i­cines through the clin­ic.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER